Table of Content

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Market


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Porters Five Force Analysis
4.3.1 Threat of New Entrants
4.3.2 Bargaining Power of Buyers/Consumers
4.3.3 Bargaining Power of Suppliers
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Eicosapentanoic Acid (EPA)
5.1.2 Docosahexaenoic Acid (DHA)
5.1.3 EPA/DHA
5.2 By Application
5.2.1 Functional Food and Beverage
5.2.2 Infant Formula
5.2.3 Dietary Supplements
5.2.4 Pharmaceuticals
5.2.5 Clinical Nutrition
5.2.6 Animal Nutrition
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.1.4 Rest of North America
5.3.2 Europe
5.3.2.1 United Kingdom
5.3.2.2 France
5.3.2.3 Germany
5.3.2.4 Spain
5.3.2.5 Russia
5.3.2.6 Italy
5.3.2.7 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 Rest of Asia-Pacific
5.3.4 South America
5.3.4.1 Brazil
5.3.4.2 Argentina
5.3.4.3 Rest of South America
5.3.5 Middle-East
5.3.5.1 South Africa
5.3.5.2 Saudi Arabia
5.3.5.3 Rest of Middle-East


6 COMPETITIVE LANDSCAPE
6.1 Market Positioning of Players
6.2 Strategies Adopted by Leading Players
6.3 Company Profiles
6.3.1 Archer Daniels Midland Company
6.3.2 Koninklijke DSM NV
6.3.3 Corbion NV
6.3.4 Solutex
6.3.5 Polaris SA
6.3.6 BASF SE
6.3.7 Lonza
6.3.8 AlgaeCytes Limited
6.3.9 Novotech Nutraceuticals Inc.
6.3.10 Bioprocess Algae LLC


7 MARKET OPPORTUNITIES AND FUTURE TRENDS


8 IMPACT OF COVID-19 ON THE MARKET